Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Grape seed extract for lowering high-normal blood pressure

Official title: Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial

Run by Indena S.p.A · NCT07090876 · Data updated 2026-11-12

This will test whether a standardized grape seed extract can lower systolic blood pressure in adults with high-normal blood pressure who follow a low-sodium Mediterranean diet.

More High Blood Pressure trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment60 (estimated)
SponsorIndena S.p.A
Industry-sponsored
Locations1 site (Bologna, Bo)
StatusRecruiting
StartedApril 10, 2026
Main results expectedJanuary 30, 2027
Study endsJanuary 30, 2027
Registry record updatedApril 22, 2026
Trial IDNCT07090876 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–70 with systolic BP 130–139 mmHg and/or diastolic BP 85–89 mmHg, a 10-year CVD risk <10%, able to follow a low-sodium Mediterranean diet and attend study visits are ideal candidates.

Probably not a fit

People taking blood-pressure–affecting drugs or supplements, with unstable chronic conditions, significant liver or kidney disease, pregnant or breastfeeding, or with higher cardiovascular risk are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, placebo-controlled study compares a standardized grape seed extract supplement to placebo in adults aged 18–70 with high-normal blood pressure who are following a low-sodium Mediterranean diet. The primary outcome is change in systolic blood pressure, with secondary outcomes including diastolic blood pressure, other hemodynamic parameters, and the Perceived Stress Score. Eligible participants must have a 10-year cardiovascular risk below 10% and no unstable chronic conditions or confounding medications. The trial is sponsored by Indena S.p.A and conducted at the Cardiovascular Internal Medicine Unit, IRCCS University Hospital of Bologna.

Why it matters

Potential benefit: If effective, the supplement could offer a non-pharmacological option to modestly lower systolic blood pressure and potentially reduce long-term cardiovascular risk in people with high-normal blood pressure.

How similar studies have gone: Small randomized trials and meta-analyses report modest blood-pressure reductions with grape seed extract, but findings are mixed and larger rigorous trials are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female subjects aged ≥18 and ≤70 years;
* Subjects with high-normal blood pressure levels, defined as SBP 130-139 mmHg and/or DBP 85-89 mmHg (according to ESH criteria);
* Subjects with an estimated 10-year CVD risk \<10% (as per the SCORE risk prediction algorithm of the European Society of Cardiology);
* Subjects capable of communicating, making themselves understood, and complying with the study requirements;
* Subjects who agree to participate in the study and have dated and signed the informed consent form.

Exclusion Criteria:

* Treatment with direct vasodilator drugs or supplements known to affect blood pressure levels;
* Chronic pharmacological treatments for any clinical condition not stabilized for at least 3 months;
* Known thyroid, renal, or hepatic dysfunction (including transaminase levels ≥3 times the upper limit of normal \[ULN\]);
* Current or past history of alcohol abuse;
* Pregnancy or breastfeeding;
* Known intolerance or hypersensitivity to the active ingredients of the investigational dietary supplement;
* History or clinical evidence of any significant concomitant disease that could compromise subject safety or the ability to complete the study.

Where it's running

  • Cardiovascular Internal Medicine Unit, IRCCS University Hospital of Bologna, Bologna, Italy
    Bologna, Bo, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.